X Genomics Inc . (NASDAQ:TXG) reported its Q4 2024 earnings, revealing a larger-than-expected loss per share and a decline in revenue compared to the previous year. The company posted an EPS of -$0.40 ...

Genomics (TXG) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.41 per share a year ago. These figures are adjusted ...

Reports Q4 revenue $165.0M, consensus $164.98M. “In 2024, we launched major new products across all three of our platforms and we made changes ...

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Wednesday reported a loss of $49 million in its fourth quarter. The Pleasanton, California-based company said it had a ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

The Alfredson protocol is a treatment for Achilles tendonitis that involves repeated eccentric heel drop exercises. In this exercise, the heel is slowly lowered off a step while the toes stay on the ...

For now, its potential for a 10x in 2025 remains ambitious but not impossible. NEAR Protocol has carved out a reputation for offering one of the most user-friendly and scalable blockchain platforms ...

Altcoin season is here, and analysts have cast their predictions for Litecoin, Near Protocol, Polygon en Rolblok. Litecoin is already recovering, as the price rebounded 12% in the last month from a ...

The Dassault Falcon 10X is a long-range business jet that is being developed by French aircraft manufacturer, Dassault Aviation. It was expected that certification and development will take place ...